Search

Search Constraints

You searched for: Author/Creator Vescio, Robert

Search Results

1. A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients. Issue 5 (14th August 2022)

2. A phase 2 trial of the efficacy and safety of elotuzumab in combination with pomalidomide, carfilzomib and dexamethasone for high-risk relapsed/refractory multiple myeloma. Issue 4 (21st March 2022)

3. Intermediate‐term outcomes of heart transplantation for cardiac amyloidosis in the current era. Issue 6 (19th April 2021)

4. Mechanical circulatory support for cardiac amyloidosis. Issue 10 (29th July 2019)

5. Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma. (9th December 2022)

6. Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma. (21st November 2017)

7. Successful autologous hematopoietic stem cell transplants using Salmonella positive products collected from asymptomatic donors. Issue 4 (7th March 2023)